PER 1.27% 8.0¢ percheron therapeutics limited

Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-596

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,710 Posts.
    lightbulb Created with Sketch. 1097
    venBio Select Advisor holds $212.7 million of Sarepta stock.

    Adage Capital Management holds $182.3 million

    These elephants have deep knowledge of the challenges Sarepta faces re FDA efficacy queries.

    They have large positions in Sarepta they need to protect.

    No doubt Goolsbee will be key player going forward as the ANP story unfolds.

    .
    Last edited by Uboy: 16/10/19
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.